Virtual Agent Feasibility in Oncology Patients (NTT Data)

Ki vehet részt

• Willing and able to provide written informed consent and HIPAA authorization for the release of personal health information
• Age ≥18
• Cancer (solid tumor)
• Planning to return to Duke Cancer Center clinic for three days in a row; Patients whose treatment does not require that they return to clinic for three days in a row, but who are willing to voluntarily return to participate in this study are permitted to enroll
• Eastern Cooperative Oncology Group (ECOG) score of 0-2
• Native fluency of spoken English as determined by the investigator; Non-native English speakers are permitted to enroll if they have achieved native fluency
• Vitals as collected by the clinic using Duke maintained equipment must be within the ranges specified by the remote patient monitoring devices; Weight ≤ 180 kg; Systolic blood pressure ≤ 300 mmHg; Pulse rate of 40-200 bpm; SpO2 of 70-100%; Temperature 34.0-42.2°C
• Arm circumference of 22-42 cm

Ki nem vehet részt

• 1. Vision, speech, auditory, physical, cognitive or other impairment that has the potential to interfere with the use of the remote patient monitoring device or agent, in the opinion of the investigator or study coordinator
• Has an implanted pacemaker, arterio-venus (A-V) shunt, a history of mastectomy or lymph node clearance, history of severe blood flow problems or blood disorders, or a history of severe circulatory deficit in the arm
• Is pregnant